ConductScience.org, home

Paper6371017

Chemotherapy in advanced ovarian cancer.

Rodenburg CJ and 1 other. J Cancer Res Clin Oncol, 1984. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy in advanced ovarian cancer. Papers, record 6371017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6371017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy in advanced ovarian cancer.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2025-07-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodenburg CJC J
2Cleton FJF J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Ovarian NeoplasmsMajor topic
Alkylating Agents
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Female
Humans
Injections, Intraperitoneal
Neoplasm Staging
Prognosis
Random Allocation
Time Factors

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1175277Management of ovarian carcinoma. Current concepts and future prospects.N Engl J Med1976https://conductscience.org/library/papers/175277PubMed
26131277JMS, successor to cisplatin in advanced ovarian carcinoma?Lancet1983https://conductscience.org/library/papers/6131277PubMed
3406560Acute leukemia after alkylating-agent therapy of ovarian cancer.N Engl J Med1977https://conductscience.org/library/papers/406560PubMed
46752720Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.N Engl J Med1982https://conductscience.org/library/papers/6752720PubMed
57471076Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.Cancer Res1980https://conductscience.org/library/papers/7471076PubMed
67378989
Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
Cancer1980https://conductscience.org/library/papers/7378989PubMed
7110083Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.AJR Am J Roentgenol1979https://conductscience.org/library/papers/110083PubMed
86787963Epithelial carcinoma of the ovary: current strategies.Ann Intern Med1981https://conductscience.org/library/papers/6787963PubMed
95892067The role of chemotherapy in the treatment of gynecologic malignancy.Am J Obstet Gynecol1965https://conductscience.org/library/papers/5892067PubMed
107105021Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.Cancer Res1982https://conductscience.org/library/papers/7105021PubMed
116796106Medical Research Council study on chemotherapy in advanced ovarian cancer. Medical Research Council's Working Party on ovarian cancer.Br J Obstet Gynaecol1981https://conductscience.org/library/papers/6796106PubMed
126681730Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.Cancer Res1983https://conductscience.org/library/papers/6681730PubMed
13101843Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.N Engl J Med1978https://conductscience.org/library/papers/101843PubMed
146258537Surgical management of ovarian cancer.Arch Surg1981https://conductscience.org/library/papers/6258537PubMed
15107464Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.Neth J Med1979https://conductscience.org/library/papers/107464PubMed
166110955Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma.Lancet1981https://conductscience.org/library/papers/6110955PubMed
176890785Intraperitoneal cisplatin with systemic thiosulfate protection.Ann Intern Med1982https://conductscience.org/library/papers/6890785PubMed
18219695Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer.Am J Obstet Gynecol1979https://conductscience.org/library/papers/219695PubMed
194962186Chemotherapy of ovarian cancer.Int Surg1967https://conductscience.org/library/papers/4962186PubMed
20445503Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.Cancer Treat Rep1979https://conductscience.org/library/papers/445503PubMed

See all 29 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn Papers
19487811Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy.J Clin Invest2009https://conductscience.org/library/papers/19487811

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6371017

GET https://conductscience.org/api/papers/v1/6371017/references?page=2